CP
Capricorn Partners
Venture CapitalActiveCapricorn Partners is a Belgium-based manager of project capital and equity funds which invests in technology companies.
80
Investments
10
Exits
$1.2B
AUM
12.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Capricorn Partners.
Investment Thesis & Strategy
Capricorn Partners invests in technology companies across various stages, leveraging its expertise in asset management, fintech, and venture capital.
Investment Activity
Deals per year over the last 10 years
1
20123
20131
20140
20151
20160
20172
20181
20190
20203
2021Portfolio Companies
Selected investments from their portfolio of 80 companies
A
Aphea.Bio
Biotech · Series A, 2021
I
Inarix
Biotech · Series A, 2021
R
Rejuvenate Biomed
Biotech · Series A, 2021
O
Oncomfort
Healthcare · Series B, 2019
A
AgroSavfe
Biotech · Series B, 2018
X
Xylos
Biotech · Series A, 2018
Q
Q-Biologicals
Biotech · Growth, 2016
i
iTeos Therapeutics
Biotech · Series A, 2014
G
Globisens
EdTech · Growth, 2013
B
Biotalys
Biotech · Series A, 2013
V
Viroclinics Biosciences
Biotech · Growth, 2013
e
e-Xstream engineering
Enterprise · Growth, 2012
Notable Exits
CompanyTypeYearValue / Acquirer
NexeonAcquisition2024—
SilexicaAcquisition2023—
EpycAcquisition2023—
XeltisAcquisition2023—
InnoSenTAcquisition2022—
MicroPort CRMIPO2021—
Surgical ScienceIPO2021—
BiotronikAcquisition2020—
SynthonAcquisition2019—
AvantiumIPO2019—
Frequently Asked Questions
Capricorn Partners focuses on Series A, Series B, Series C+ stage investments.